Chronic liver damage leads to scarring (fibrosis) of the liver tissue.
This can ultimately lead to increased blood pressure in the vascular system of the gastrointestinal tract (i.e. portal hypertension), which can result in serious complications.
In a recent study published in Gut, researchers showed that the increasing severity of this type of high blood pressure is paralleled by inflammation in the body.
They also found common high blood pressure drugs beta-blockers have anti-inflammatory effects in advanced liver disease.
The research was conducted by a team at MedUni Vienna. One author of the study is Thomas Reiberger.
For many years, beta-blockers have been used as standard drug treatment, but only 50% to 60% of patients achieve a clinically relevant reduction in portal vein pressure.
The current study found that beta-blockers also have an impact on systemic inflammation.
In this study, the researchers found biomarkers of systemic inflammation prior to and subsequently during treatment with beta-blockers.
They showed that patients suffering from advanced stages of cirrhosis were not only more likely to have a systemic inflammatory response but were also more likely to benefit from the anti-inflammatory effects of beta-blockers.
The cirrhotic patients achieved a reduction in inflammatory markers (such as the white blood cell count) under beta-blocker therapy, and they had much fewer complications of portal hypertension and had a lower death risk.
The team says after further validation in clinical trials, these findings may help to predict the benefit of beta-blocker treatment more accurately and thus to give patients optimal advice.
If you care about high blood pressure, please read studies about this eating habit may lower high blood pressure caused by diabetes and findings of how to keep high blood pressure in check.
For more information about blood pressure health, please see recent studies about these people more likely to have uncontrolled high blood pressure and results showing that intensive blood pressure lowering can benefit older people with hypertension.
Copyright © 2021 Knowridge Science Report. All rights reserved.
